High Dietary Iron Supplement Induces the Nigrostriatal Dopaminergic Neurons Lesion in Transgenic Mice Expressing Mutant A53T Human Alpha-Synuclein

Frontiers in Aging Neuroscience
Fengju JiaHong Jiang

Abstract

Both alpha-synuclein aggregation and iron deposits are neuropathological hallmarks of Parkinson's disease (PD). We are particularly interested in whether iron could synergize with alpha-synuclein pathology in vivo, especially in the nigrostriatal system. In the present study, we reported transgenic mice with overexpressing human A53T alpha-synuclein, as well as WT mice with high dietary iron displayed hyperactive motor coordination and impaired colonic motility, compared with those with basal dietary iron. Only A53T mice, but not WT mice with high dietary iron exhibited nigral dopaminergic neuronal loss, lower levels of tyrosine hydroxylase (TH) in the substantia nigra (SN) and decreased dopamine contents in the striatum. Although there was no obvious elevation of iron contents in the SN in WT mice with high dietary iron, we observed iron contents in the SN were especially higher than the other brain regions in 12-month aged mice with either high or basal dietary iron. These results suggested high dietary iron supplement could induce nigral dopaminergic neurons lesion in A53T mice, which might be due to the vulnerability of SN to accumulate iron.

References

Sep 1, 1994·Journal of Neurochemistry·M GerlachMoussa B H Youdim
Aug 30, 2000·Acta Neuropathologica·R J CastellaniM A Smith
Jul 4, 2001·Nature Reviews. Neuroscience·M Goedert
May 27, 2003·Journal of Cellular Physiology·Ya KeZhong-Ming Qian
Sep 16, 2003·Neuron·William Dauer, S Przedborski
Mar 4, 2005·Journal of Cellular Physiology·Yan-Zhong ChangYa Ke
Jul 7, 2005·Journal of the American Chemical Society·Lucy L Liu, Katherine J Franz
Jun 13, 2006·Neurobiology of Aging·Deepinder KaurJulie K Andersen
Oct 21, 2006·Journal of Computational Neuroscience·Poorvi KaushikShireen Vali
Nov 4, 2006·Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry·Lucy L Liu, Katherine J Franz
May 23, 2007·Journal of Cellular Biochemistry·Zhong-Ming QianYa Ke
Jan 4, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Jinfang WuNasser H Zawia
Nov 18, 2008·Proceedings of the National Academy of Sciences of the United States of America·Julio SalazarE C Hirsch
Jun 11, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Paolo BaronePRIAMO study group
Aug 20, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Michela BarichellaGianni Pezzoli
Oct 22, 2010·Trends in Neurosciences·Lara Lourenço VendaRichard Wade-Martins
Mar 15, 2011·FEBS Letters·Adam W Oaks, Anita Sidhu
Jun 19, 2012·Neurología : publicación oficial de la Sociedad Española de Neurología·J Campdelacreu
Nov 15, 2012·Sub-cellular Biochemistry·Sueli Marques, Tiago Fleming Outeiro
Feb 8, 2013·Movement Disorders : Official Journal of the Movement Disorder Society·C Warren Olanow, Patrik Brundin
Feb 14, 2013·Brain : a Journal of Neurology·Tao Wu, Mark Hallett
Nov 22, 2013·Biochemical Society Transactions·D R Brown
Dec 19, 2013·Nature Chemical Biology·Scott J Dixon, Brent R Stockwell
Jul 1, 2014·Current Opinion in Neurology·Jennifer G Goldman, Ron Postuma
Mar 12, 2015·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Madison T Gray, John M Woulfe
Nov 8, 2015·Journal of Neurochemistry·Abdel A Belaidi, Ashley I Bush
Jan 12, 2016·PloS One·Marcio S MedeirosMichele Rechia Fighera
Feb 4, 2016·Proceedings of the National Academy of Sciences of the United States of America·Mohamed-Bilal FaresHilal A Lashuel
Feb 13, 2016·Metallomics : Integrated Biometal Science·J S McDowall, D R Brown
Mar 5, 2016·Journal of Geriatric Psychiatry and Neurology·Fang WangWei Zhang
Mar 31, 2016·Movement Disorders : Official Journal of the Movement Disorder Society·Dimitra PapadimitriouLeonidas Stefanis
Apr 4, 2016·Molecular Neurobiology·Hong JiangJun-Xia Xie
Jul 20, 2016·Journal of Clinical Gastroenterology·Saloua MrabetSamir Belal
Feb 9, 2017·Journal of Neural Transmission·Paul LingorJan Christoph Koch
Apr 13, 2017·Neurobiology of Disease·Emily M RochaLaurie H Sanders
Apr 19, 2017·Current Environmental Health Reports·S M Fleming
Aug 7, 2017·Parkinsonism & Related Disorders·D Dickson

Methods Mentioned

BETA
transgenic
Assay

Related Concepts

Related Feeds

Alpha-Synuclein Aggregation

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.